Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2010
01/13/2010EP1869018B1 3-triazolylthioalkyl-3-azabicyclo (3 - 1 - o) hexanes and their use as dopamine d3 receptor ligands
01/13/2010EP1641805B1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases
01/13/2010EP1451160B1 Pyrazole-amides for use in the treatment of pain
01/13/2010EP1144388B1 Acyl derivatives which treat vla-4 related disorders
01/13/2010CN101627037A Piperidine GPCR agonists
01/13/2010CN101627036A 哌啶gpcr激动剂 Piperidine gpcr agonists
01/13/2010CN101627035A Piperidine GPCR agonists
01/13/2010CN101627034A Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
01/13/2010CN100579976C P38 inhibitors and methods of use thereof
01/13/2010CN100579957C Novel arylamidine derivative or salt thereof
01/12/2010US7645891 E.g., 4-(2-methyl-3-oxo-hept-6-en-2-yl)-2,2-dimethyl-[1,3]-dioxane chemical intermediate; chemical/metabolic stabilization of microtubuli; antitumor, -carcinogenic agents; malignant melanoma, acute lymphocytic/myelocytic leukemia; angiogenesis inhibitors; antiinflammatory/-arthritic agents; psoriasis
01/12/2010US7645781 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
01/12/2010US7645776 (R)-1-{2-[3-(4-Methoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-2-phenoxy-ethanone; carnitine-dependent palmitoyltransferases (CPTs); reduce liver beta -oxidation, consequently inhibit gluconeogenesis and therefore counteract hyperglycemia
01/12/2010US7645775 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
01/12/2010US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
01/12/2010US7645770 Phenylalanine enamide derivatives
01/12/2010US7645764 Kinase inhibitors and methods for using the same
01/12/2010US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/12/2010US7645755 5-Cyano-1H-imidazole-2-carboxylic acid [4-(3,6-dihydro-2H-pyran-4-yl)-2-(4,4-dimethyl-cyclohex-1-enyl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent
01/12/2010US7645751 Mandelic acid derivatives and their use as thrombin inhibitors
01/12/2010CA2413723C Method for producing 4-bromine-aniline derivatives
01/12/2010CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
01/12/2010CA2375834C Process for making taxane derivatives
01/12/2010CA2324339C Piperidine derivatives
01/12/2010CA2287219C 2-oxo-1-azetidine sulfonic acid derivatives as potent .beta.-lactamase inhibitors
01/12/2010CA2192089C Inhibitors of interleukin-1.beta. converting enzyme
01/07/2010WO2010003048A1 Benzimidazoles and related analogs as sirtuin modulators
01/07/2010WO2010002655A2 Compounds and compositions as kinase inhibitors
01/07/2010WO2010002115A2 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
01/07/2010WO2010001946A1 Triazole derivative or salt thereof
01/07/2010WO2010001869A1 Tetra-substituted benzene compound and use thereof
01/07/2010WO2010001126A1 Thiophene derivatives as kinase inhibitors
01/07/2010WO2010000773A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
01/07/2010WO2010000748A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities
01/07/2010WO2010000704A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
01/07/2010WO2010000703A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
01/07/2010WO2010000633A1 Novel phenylpyrazinones as kinase inhibitors
01/07/2010WO2010000353A1 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
01/07/2010WO2010000073A1 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
01/07/2010WO2009121535A3 Antiproliferative compounds and therapeutic uses thereof
01/07/2010WO2009103432A3 Covalently binding imaging probes
01/07/2010US20100004439 Heterocyclic Compound
01/07/2010US20100004438 Diarylether derivatives as antitumor agents
01/07/2010US20100004292 Iminooxazolidine Derivatives and Their Use
01/07/2010US20100004284 Novel Heterocyclic Compounds as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
01/07/2010US20100004265 1,2,3-triazole derivatives as sigma receptor inhibitors
01/07/2010US20100004263 Mtp inhibiting aryl piperidines or peperazines substituted with5-membered heterocycles
01/07/2010US20100004254 Therapeutic agents useful for treating pain
01/07/2010US20100004245 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
01/07/2010US20100004243 Pharmaceutical compounds
01/07/2010US20100004242 Process for the preparation of aprepitant
01/07/2010US20100004240 Indole Compounds
01/07/2010US20100004239 Pyrrolo [3,2-C] Pyridine-4-One 2-Indolinone Protein Kinase Inhibitors
01/07/2010US20100004236 Phosphodiesterase 4 inhibitors
01/07/2010US20100004235 Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses
01/07/2010US20100004233 Novel coumarin derivative having antitumor activity
01/07/2010US20100004231 Inhibitors of burton's tyrosine kinase
01/07/2010US20100004228 calcitonin gene related peptide antagonists such as [(3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-[4-[1-(3-ethoxy-3-oxopropyl)piperidin-4-yl]piperidin-1-yl]-1-oxopropan-2-yl]4-(3-oxo-5-phenyl-1H-1,2,4-triazol-2-yl)piperidine-1-carboxylate; headaches; diabetes; irritable bowel syndrome; hot flashes
01/07/2010US20100004224 1,2,4-triazole derivatives as sigma receptor inhibitors
01/07/2010US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
01/07/2010US20100004220 Indenoisoquinolinone Analogs and Methods of Use Thereof
01/07/2010US20100004219 Modulators of glucocorticoid receptor, ap-1, and/or nf-kappabeta activity and use thereof
01/07/2010US20100004207 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
01/07/2010US20100004128 Herbicidal isoxazoline compounds
01/07/2010US20100004127 3'-alkoxyspirocyclopentyl-substituted tetramic and tetronic acids
01/07/2010US20100003216 HCV NS-3 Serine Protease Inhibitors
01/07/2010CA2729724A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
01/07/2010CA2729710A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities
01/07/2010CA2729495A1 Pyrimidine derivatives as kinase inhibitors
01/07/2010CA2729493A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
01/07/2010CA2729491A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
01/07/2010CA2729408A1 Triazole derivative or salt thereof
01/07/2010CA2729246A1 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
01/07/2010CA2729128A1 Benzimidazoles and related analogs as sirtuin modulators
01/07/2010CA2728683A1 Novel phenylpyrazinones as kinase inhibitors
01/07/2010CA2728350A1 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
01/06/2010EP2141162A1 3-(n-heterocyclyl)-pyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
01/06/2010EP2141161A1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
01/06/2010EP2141154A1 Oxazolidinone derivative having inhibitory activity on 11 -hydroxysteroid dehydrogenase type i
01/06/2010EP2141152A1 Compound for organic electroluminescent device and organic electroluminescent device
01/06/2010EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods
01/06/2010EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods
01/06/2010EP2139887A2 Metalloprotease inhibitors containing a heterocyclic moiety
01/06/2010EP2139886A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity
01/06/2010EP2139881A1 Quinolines and their therapeutic use
01/06/2010EP2139880A1 Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
01/06/2010EP2139874A2 Isoxazoline compounds and their use in pest control
01/06/2010EP2139857A1 Sub-type selective azabicycloalkane derivatives
01/06/2010EP1773338B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
01/06/2010EP1735278B1 Histamine h3 receptor agents, preparation and therapeutic uses
01/06/2010EP1489078B1 Benzofuran derivative
01/06/2010EP0934281B1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators
01/06/2010CN101622251A Salt of heterocycle-substituted pyridine derivative or crystal thereof
01/06/2010CN101622250A Piperidine GPCR agonists
01/06/2010CN101622249A Piperidine GPCR agonists
01/06/2010CN101619061A Cyanopyridyl-replaced oxazolidinone compound
01/06/2010CN101619060A Heterocyclic compound, composite containing same and using method thereof
01/06/2010CN101619057A N-substituted piperidine derivatives as serotonin receptor agents
01/06/2010CN100577660C N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists used for the treatment of diabetes
01/06/2010CN100577658C 喹唑啉衍生物 Quinazoline derivatives